Ensuring Patient Access to Critical Breakthrough Products Act of 2018
Official title: To amend titles XVIII and XIX of the Social Security Act to ensure prompt coverage of breakthrough devices under the Medicare and Medicaid programs, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Ensuring Patient Access to Critical Breakthrough Products Act of 2018
This bill (1) allows designated medical breakthrough devices to be temporarily covered under Medicare during a specified transitional period, (2) establishes a process to allow for continued coverage after the transitional period has expired, and (3) modifies other Medicare payment systems relating to new medical technology.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 5997: Ensuring Patient Access to Critical Breakthrough Products Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-HR-5997/
"H.R. 5997: Ensuring Patient Access to Critical Breakthrough Products Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-5997/.
H.R. 5997, 115th Cong. (2026), https://openamerica.io/bill/115-HR-5997/.
[H.R. 5997: Ensuring Patient Access to Critical Breakthrough Products Act of 2018](https://openamerica.io/bill/115-HR-5997/)